Brewin Dolphin LTD Abb Vie Inc. Transaction History

Brewin Dolphin LTD

$2.08 Billion
Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Brewin Dolphin LTD holds 22,008 shares of ABBV stock, worth $4.29 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

22,008

Previous 22,113 0.47%

Holding current value

$4.29 Million

Previous $3.59 Million 5.97%

% of portfolio

0.16%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 14, 2022	SELL	$137.62 - $174.96 $14,450 - $18,370	-105 Reduced 0.47%	22,008 $3.37 Million
Q1 2022 Nov 14, 2022	SELL	$131.98 - $163.75 $88,954 - $110,367	-674 Reduced 2.96%	22,113 $3.59 Million
Q4 2021 Nov 14, 2022	BUY	$107.43 - $135.93 $2.45 Million - $3.1 Million	22,787 New	22,787 $3.09 Million
Q3 2021 Nov 09, 2023	SELL	$106.4 - $120.78 $53,200 - $60,390	-500 Reduced 1.63%	30,262 $3.26 Billion
Q2 2021 Nov 09, 2023	BUY	$105.21 - $117.21 $39,453 - $43,953	375 Added 1.23%	30,762 $3.47 Billion
Q1 2021 Nov 09, 2023	BUY	$102.3 - $112.62 $63,426 - $69,824	620 Added 2.08%	30,387 $3.29 Billion
Q4 2020 Nov 09, 2023	SELL	$80.49 - $108.67 $26,078 - $35,209	-324 Reduced 1.08%	29,767 $3.19 Billion
Q3 2020 Nov 09, 2023	SELL	$85.91 - $100.83 $1.09 Million - $1.28 Million	-12,743 Reduced 29.75%	30,091 $2.64 Billion
Q2 2020 Nov 09, 2023	BUY	$73.37 - $98.18 $25,239 - $33,773	344 Added 0.81%	42,834 $4.21 Billion
Q1 2020 Nov 09, 2023	BUY	$64.5 - $97.79 $15,028 - $22,785	233 Added 0.55%	42,490 $3.24 Billion
Q4 2019 Nov 09, 2023	BUY	$72.13 - $90.25 $23,802 - $29,782	330 Added 0.79%	42,257 $3.74 Billion
Q3 2019 Nov 09, 2023	SELL	$62.98 - $75.72 $19,523 - $23,473	-310 Reduced 0.73%	41,927 $3.17 Billion
Q2 2019 Nov 09, 2023	BUY	$65.7 - $83.98 $1,971 - $2,519	30 Added 0.07%	42,237 $3.07 Billion
Q1 2019 Nov 09, 2023	BUY	$77.14 - $90.79 $67,111 - $78,987	870 Added 2.1%	42,207 $3.4 Billion
Q3 2018 Nov 09, 2023	SELL	$88.91 - $98.84 $5,334 - $5,930	-60 Reduced 0.14%	41,337 $3.91 Billion
Q2 2018 Nov 09, 2023	SELL	$89.78 - $106.23 $265,299 - $313,909	-2,955 Reduced 6.66%	41,397 $3.84 Billion
Q1 2018 Nov 09, 2023	BUY	$92.01 - $123.21 $210,242 - $281,534	2,285 Added 5.43%	44,352 $4.2 Billion
Q4 2017 Nov 09, 2023	SELL	$89.56 - $98.21 $895 - $982	-10 Reduced 0.02%	42,067 $4.07 Billion
Q3 2017 Nov 09, 2023	BUY	$69.85 - $89.22 $1.4 Million - $1.79 Million	20,069	42,077 $3.74 Billion

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Account

Brewin Dolphin LTD Abb Vie Inc. Transaction History